Narrative review / 2011
Evidence from randomized controlled trials does not support the use of oral DHEA therapy in postmenopausal women.
This clinical review evaluated randomized controlled trials (RCTs) through November 2010 investigating DHEA therapy in postmenopausal women with normal adrenal function. While cross-sectional studies suggested associations between low DHEA levels and impaired sexual function, well-being, and cognitive performance, placebo-controlled RCTs showed no benefits of oral DHEA for these outcomes. In addition, oral DHEA did not demonstrate favorable effects on lipids or carbohydrate metabolism.
- Study type
- Clinical narrative review
- Who was studied
- Postmenopausal women with normal adrenal function
- What was measured
- Sexual function, well-being, metabolic parameters (lipids and carbohydrate metabolism), and cognition
THE PAPER
Clinical review: DHEA replacement for postmenopausal women.
Davis SR, Panjari M, Stanczyk FZ. J Clin Endocrinol Metab, 2011.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.